The recombinant protein market is fragmented with a diverse portfolio of biopharmaceutical drugs and services including hormones, cytokines, enzymes, blood factors and growth factors which are used in therapeutic areas including oncology, metabolism, hematology, infectious diseases, endocrinology and ophthalmology. The recombinant proteins offer advantages of high efficacy, low toxicity, and...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian